Strenght Training in Osteoporosis Prevention
- Conditions
- Osteopenia or Osteoporosis
- Registration Number
- NCT06733064
- Lead Sponsor
- Mateusz Karnia
- Brief Summary
The study involves 120 women over the age of 50.
All participants in the study take part in high-intensity strength training for 10 months.
In addition, half of the participants receive vitamin D3 at a dose of 4,000 IU/day.
The investigators hypothesize that training combined with vitamin D3 supplementation will be more effective in preventing osteoporosis than training alone.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Female
- Target Recruitment
- 120
- age over 50
- female
- ongoing cancer,
- unstabilized cardiovascular disease,
- cognitive disorders,
- radiological treatment in the last 12 months,
- other contraindications to undertaking high-intensity strength training,
- diseases affecting the skeleton such as: Paget's disease, type I diabetes mellitus,
- taking medications affecting skeletal conditions including: long-term therapy with corticosteroids, thiazides, antiretroviral drugs,
- contraindications to taking vitamin D including: hypercalcemia, nephrolithiasis, sarcoidosis, lack of cholecalciferol hydroxylase activity in the liver and kidneys.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Bone Mineral Density Measured at 3 time points: before the experiment, after 10 months of training, and at 6 months after the end of training and supplementation. Test to determine bone mineral density by densitometry.
- Secondary Outcome Measures
Name Time Method Vitamin D metabolites level Measured at 4 time points: before the experiment, after 5 and 10 months of training, and at 6 months after the end of training and supplementation. Measurement evaluating the levels of selected vitamin D3 metabolites by LC-MS.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Gdańsk, Faculty of Biology
🇵🇱Gdańsk, Poland